Identification of small molecule inhibitors of protein aggregation using ESI-IMS–MS.
Characterisation of binding mode as negative, specific, non-specific or colloidal.
High throughput ligand screening using ESI-IMS–MS.
Identification of novel small molecule inhibitors of Aβ40 aggregation.